[go: up one dir, main page]

OA02583A - Procédé de préparation de bis-benzimidazoles porteurs de substituants basiques. - Google Patents

Procédé de préparation de bis-benzimidazoles porteurs de substituants basiques.

Info

Publication number
OA02583A
OA02583A OA52892A OA52892A OA02583A OA 02583 A OA02583 A OA 02583A OA 52892 A OA52892 A OA 52892A OA 52892 A OA52892 A OA 52892A OA 02583 A OA02583 A OA 02583A
Authority
OA
OAPI
Prior art keywords
bis
preparation
basic substituents
carrying basic
benzimidazoles
Prior art date
Application number
OA52892A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of OA02583A publication Critical patent/OA02583A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
OA52892A 1966-04-01 1967-04-01 Procédé de préparation de bis-benzimidazoles porteurs de substituants basiques. OA02583A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEF0048833 1966-04-01

Publications (1)

Publication Number Publication Date
OA02583A true OA02583A (fr) 1970-05-05

Family

ID=7102516

Family Applications (1)

Application Number Title Priority Date Filing Date
OA52892A OA02583A (fr) 1966-04-01 1967-04-01 Procédé de préparation de bis-benzimidazoles porteurs de substituants basiques.

Country Status (9)

Country Link
US (1) US3538097A (fr)
BE (1) BE696499A (fr)
CH (2) CH533124A (fr)
DE (1) DE1670684A1 (fr)
FR (2) FR1519964A (fr)
GB (1) GB1186723A (fr)
MY (1) MY7100120A (fr)
NL (1) NL6704539A (fr)
OA (1) OA02583A (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4091101A (en) * 1977-06-15 1978-05-23 Merck & Co., Inc. 6-(1-Piperazinyl)quinoxaline
DE3611343A1 (de) * 1986-04-04 1987-10-08 Boehringer Mannheim Gmbh Heterocyclisch substituierte benzimidazole, verfahren zu ihrer herstellung, arzneimittel sowie zwischenprodukte
AU695936B2 (en) * 1994-08-26 1998-08-27 Auckland Division Cancer Society Of New Zealand Inc Novel dna-targeted alkylating agents
WO1996006831A1 (fr) * 1994-08-26 1996-03-07 Auckland Division Cancer Society Of New Zealand Inc. Nouveaux agents d'alkilation cibles sur l'adn
US5807874A (en) * 1995-05-17 1998-09-15 Rutgers, The State University Of New Jersey Trisbenzimidazoles useful as topoisomerase I inhibitors
US5767142A (en) * 1996-03-20 1998-06-16 Rutgers, The State University Of New Jersey Trisbenzimidazoles useful as topoisomerase I inhibitors
AUPN449295A0 (en) 1995-07-28 1995-08-24 Inner And Eastern Health Care Network, The Radioprotectors
US5981541A (en) * 1996-09-23 1999-11-09 Rutgers, The State University Of New Jersey Substituted heterocycles as anti-tumor agents
US6140328A (en) 1997-12-12 2000-10-31 Rutgers, The State University Of New Jersey Heterocyclic cytotoxic agents
AU753268B2 (en) * 1997-12-31 2002-10-10 Jun Sung Kim Heterocyclic topoisomerase poisons
IL137351A0 (en) * 1998-02-12 2001-07-24 Univ Rutgers Heterocyclic topoisomerase poisons
US6740650B2 (en) 1999-10-29 2004-05-25 Rutgers, The State University Of New Jersey Heterocyclic cytotoxic agents
EP1453812B1 (fr) 2001-11-14 2008-08-20 Rutgers, The State University Agents cytotoxiques
WO2003051289A2 (fr) * 2001-11-14 2003-06-26 Rutgers, The State University Agents poisons de topoisomerases solubilises
ATE390923T1 (de) * 2001-11-14 2008-04-15 Univ Rutgers Topoisomerase-giftmittel
KR20050044491A (ko) * 2001-11-14 2005-05-12 루트거스, 더 스테이트 유니버시티 가용화된 토포이소머라제 독
US20050119251A1 (en) * 2001-12-21 2005-06-02 Jian-Min Fu Nicotinamide derivatives and their use as therapeutic agents
WO2004014918A1 (fr) 2002-08-09 2004-02-19 Rutgers, The State University Agents de la topoisomerase substitues par nitro et amino
US6992088B2 (en) * 2002-08-09 2006-01-31 Rutgers, The State University Of New Jersey Nitro and amino substituted heterocycles as topoisomerase I targeting agents
US6992089B2 (en) * 2002-08-09 2006-01-31 Rutgers, The University Of New Jersey Nitro and amino substituted topoisomerase agents
AU2003290818A1 (en) * 2002-11-12 2004-06-03 Edmond J. Lavoie Topoisomerase-targeting agents
WO2006034441A1 (fr) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Derives heterocycliques et leur utilisation en tant qu'inhibiteurs de la stearoyl-coa desaturase
TW200626139A (en) * 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
EP2029138A1 (fr) * 2005-06-03 2009-03-04 Xenon Pharmaceuticals Inc. Derives aminothiazole utilises en tant qu'inhibiteurs de la stearoyle-coa desaturase humaine
EP2114896B1 (fr) * 2006-12-21 2015-07-22 Peter MacCallum Cancer Institute Composés radioprotecteurs et procédés apparentés
GB0821913D0 (en) 2008-12-02 2009-01-07 Price & Co Antibacterial compounds
EP2403856B1 (fr) 2009-03-06 2012-12-19 Rutgers, The State University of New Jersey Dérivés de méthylènedioxybenzo [i]phénanthridine pour traiter le cancer
WO2010127363A1 (fr) 2009-05-01 2010-11-04 Rutgers, The State University Of New Jersey Inhibiteurs de topoisomérase
JP5712524B2 (ja) * 2009-10-28 2015-05-07 Jsr株式会社 液晶配向剤および液晶表示素子
EP3011960B1 (fr) * 2010-06-01 2020-04-15 Summit Therapeutics plc Composés pour le traitement d'une maladie associée à clostridium difficile
JP6463631B2 (ja) 2011-06-09 2019-02-06 ライゼン・ファーマシューティカルズ・エスアー Ｇｐｒ−１１９のモジュレータとしての新規化合物
GB201506660D0 (en) 2015-04-20 2015-06-03 Cellcentric Ltd Pharmaceutical compounds
GB201506658D0 (en) 2015-04-20 2015-06-03 Cellcentric Ltd Pharmaceutical compounds
US11434227B2 (en) * 2016-01-23 2022-09-06 Vibha TANDON Broad spectrum antibacterial activity of novel bisbenzimidazoles targeting topoisomerase IA and the synergistic composition of bisbenzimidazole with efflux pump inhibitors against pathogenic bacteria
US11091498B2 (en) 2016-04-04 2021-08-17 Rutgers, The State University Of New Jersey Topoisomerase poisons

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3103403A (en) * 1963-09-10 Dyeing of polyester fibers with com-
US2980690A (en) * 1957-08-30 1961-04-18 Ciba Pharm Prod Inc New basically substituted benzylbenzimidazoles
US3072661A (en) * 1960-08-24 1963-01-08 Interchem Corp New process for improved bis-imidazole vat dyestuff pigments
US3133056A (en) * 1961-05-15 1964-05-12 May & Baker Ltd N-phenylpiperazine derivatives of tetrahydrobenzodiazepines
BE631368A (fr) * 1962-04-21
NL135043C (fr) * 1963-10-11
GB1122988A (en) * 1964-10-22 1968-08-07 Fisons Pest Control Ltd Benzimidazole derivatives
US3336191A (en) * 1966-03-11 1967-08-15 Smith Kline French Lab Anthelmintic 2-amidobenzimidazoles
US3362956A (en) * 1965-08-19 1968-01-09 Sterling Drug Inc 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines

Also Published As

Publication number Publication date
MY7100120A (en) 1971-12-31
NL6704539A (fr) 1967-10-02
FR6681M (fr) 1969-02-03
GB1186723A (en) 1970-04-02
CH533124A (de) 1973-01-31
CH525902A (de) 1972-07-31
FR1519964A (fr) 1968-04-05
DE1670684A1 (de) 1970-12-03
BE696499A (fr) 1967-10-03
US3538097A (en) 1970-11-03

Similar Documents

Publication Publication Date Title
OA02583A (fr) Procédé de préparation de bis-benzimidazoles porteurs de substituants basiques.
FR1513708A (fr) Procédé de préparation de 17-acyloxy-stéroïdes
FR1523049A (fr) Procédé de préparation de cyanoalkyl-phénols
CH471833A (fr) Procédé de préparation de stéroïdes-oxazolines
CH468412A (fr) Procédé de préparation de chlordialcoylthiophosphates
CH472398A (fr) Procédé de préparation de D-homostéroïdes
OA02426A (fr) Procédé de préparation de diols-polythioethers.
OA03381A (fr) Procédé de préparation de benzène-sulfonyl-urées.
CH452518A (fr) Procédé de préparation de 17a-acyloxy-11B-hydroxystéroïdes
FR95317E (fr) Procédé de préparation de polyacyloxamidrazones.
OA03382A (fr) Procédé de préparation de benzène-sulfonyl-urées.
FR1522956A (fr) Procédé de préparation de trifluorométhyl-dibenzocycloheptène-5-ones
OA02405A (fr) Procédé de préparation de nouvelles chloroquinoleines.
FR1511323A (fr) Procédé de préparation de monohalogéno-n-alkyl-acéto-acétamides
FR1514010A (fr) Procédé de préparation de benzonaphtyridines
OA02594A (fr) Procédé de préparation de thiosemi-carbazones.
OA03625A (fr) Procédé de préparation de benzène-sulfonyl-urées.
OA03380A (fr) Procédé de préparation de benzène-sulfonyl-urées.
CH478095A (fr) Procédé de préparation des N-tertiaires-aminoalkyl-2-alcoxy-5-halogénobenzamides
FR1499401A (fr) Procédé de préparation de diènes-1, 4
CH468993A (fr) Procédé de préparation de stéroïdes-oxazolines
FR1537604A (fr) Procédé de préparation de biguanides
OA02251A (fr) Procédé de préparation de benzène-sulfonyl-urées.
FR1529455A (fr) Procédé de préparation de 5-alkylidène-nor bornènes
FR1526690A (fr) Procédé de préparation de gamma-bromo-beta-alcoxy-crotonates